• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer. Read More

Navigating Lymphoma and Survivorship in Adolescents and Young Adults

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their diagnosis. Read More

EMERALD Trial Results: What Prior CDK4/6i Duration Means for Treatment Success

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Panelists discuss how the EMERALD trial demonstrated elacestrant’s efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its FDA approval for this specific...

Managing Elacestrant Treatment: From Patient Selection to Supportive Care

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the second-line setting. Read...

Honoring a Healer: Personal Care With National Impact

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez. Read More

Breaking Barriers: Why Increasing Lung Screening is Critical

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles Lung cancer remains the leading cause of cancer-related deaths in the U.S. Read More
« Older Entries
Next Entries »

Recent Content

  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma
  • What Does Multiple Myeloma Mean?
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT